mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
5e-05 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
7e-05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
8e-05 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0001 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0003 |